Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis

OBJECTIVE: Clinical diagnosis and approval of new medications for non-alcoholic steatohepatitis (NASH) require invasive liver biopsies. The aim of our study was to identify non-invasive biomarkers of NASH and/or liver fibrosis. DESIGN: This multicentre study includes 250 patients (discovery cohort,...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelini, Giulia, Panunzi, Simona, Castagneto-Gissey, Lidia, Pellicanò, Francesca, De Gaetano, Andrea, Pompili, Maurizio, Riccardi, Laura, Garcovich, Matteo, Raffaelli, Marco, Ciccoritti, Luigi, Verrastro, Ornella, Russo, Maria Francesca, Vecchio, Fabio Maria, Casella, Giovanni, Casella-Mariolo, James, Papa, Luigi, Marini, Pier Luigi, Rubino, Francesco, le Roux, Carel W, Bornstein, Stefan, Mingrone, Geltrude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872242/
https://www.ncbi.nlm.nih.gov/pubmed/35820779
http://dx.doi.org/10.1136/gutjnl-2022-327498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872242/
https://www.ncbi.nlm.nih.gov/pubmed/35820779
http://dx.doi.org/10.1136/gutjnl-2022-327498

Ejemplares similares